The usefulness of the Bard BTA test in the diagnosis of bladder cancer.
Article published in Urologia Polska 1996/49/2.

authors

Ewa Koźmińska, Piotr Trypens, Andrzej Borkowski

Z Katedry i Kliniki Urologii Akademii Medycznej w Warszawie
Kierownik Kliniki: prof. dr hab. med. A. Borkowski

keywords

bladder neoplasms transitional cell carcinoma BTA test.

summary

Preliminary results with the use of the Bard BTA test in the diagnosis of bladder

carcinoma are presented. In the group of 33 patients we observed a high correlation of

the Bard BTA test results with cystoscopy and histopathology (81.8%; in subgroups

75.0%, 90.9%, and 83.3%, respectively).

The Bard BTA test is an useful method of the bladder cancer diagnosis. In the future

it probably could supplement cystoscopy in detection of recurrent bladder carcinoma.

Patients and methods

The Bard BTA test was performed in three groups of patients:

1) in 16 patients before a transurethral resection of primary or recurrent blad-

der carcinoma (TURT group),

u Bard BTA 1 67

2) in 11 patients before a cystoscopy for detection of primary or recurrent

bladder carcinoma (CYST group),

3) in 6 patients before a transurethral resection of the prostate for benign hy-

perplasia (control group, TURP).

Results of the test were eompared with cystoscopic and pathological findings.

Results

In the group of 33 patients we observed a high correlation of the Bard BTA test results

with cystoscopy and histopathology (81.8% totally; in TURT, CYST and TURP groups

75.0%, 90.9%, and 83.3%, respectively).

Conclusion

The Bard BTA test is an useful method of the bladder cancer diagnosis. In the future

it probably could supplement cystoscopy in detection of recurrent bladder carcinoma.

references